```

[Federal Register Volume 89, Number 179 (Monday, September 16, 2024)]
[Notices]
[Page 75542]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20944]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Meeting of the Board of Scientific Counselors Infectious Diseases

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Board of Scientific Counselors Infectious 
Diseases (BSC ID). This virtual meeting is open to the public via Zoom, 
limited only by the number of web conference lines available (500 
lines). Registration in advance is required by accessing the link below 
in the addresses section. Time will be available for public comment.

DATES: The meeting will be held on November 4 and 5, 2024, from 11 a.m. 
to 5 p.m., EST.

ADDRESSES: Zoom virtual meeting. Registration in advance is required by 
accessing the link at https://cdc.zoomgov.com/webinar/register/WN_fHWh_7peSgyUTYagidwsmg. Instructions to access the meeting will be 
provided following registration.

FOR FURTHER INFORMATION CONTACT: Sarah Wiley, M.P.H., Senior Advisor, 
National Center for Emerging and Zoonotic Infectious Diseases, Centers 
for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16-
5, Atlanta, Georgia 30329-4027. Telephone: (404) 639-4840; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Board of Scientific Counselors Infectious Diseases 
(BSC ID) provides advice and guidance to the Secretary, Department of 
Health and Human Services; the Director, Centers for Disease Control 
and Prevention (CDC); and the Directors of the National Center for 
Emerging and Zoonotic Infectious Diseases, the National Center for HIV, 
Viral Hepatitis, STD, and TB Prevention, the National Center for 
Immunization and Respiratory Diseases, and the Global Health Center, 
CDC, concerning strategies, goals, and priorities for the programs and 
research within the national centers and monitors the overall strategic 
direction and focus of CDC's infectious disease programs and centers.
    Matters to be Considered: The agenda will include updates from and 
discussions of programmatic priorities of CDC's national centers that 
address infectious diseases and will include reports from each of the 
Board's workgroups. Agenda items are subject to change as priorities 
dictate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-20944 Filed 9-13-24; 8:45 am]
BILLING CODE 4163-18-P
```